PRACTICE - Latest Update 2026/2027
,Section 1: Practice Questions & Detailed
Rationales
Question 1 (Autonomic Pharmacology:
Cholinergic Crisis vs. Myasthenic Crisis)
A patient with myasthenia gravis who is taking
neostigmine [Prostigmin] presents with extreme
muscle weakness, excessive salivation, lacrimation,
severe abdominal cramping, and miosis. What
diagnostic or therapeutic action should the nurse
anticipate?
• A. Administer Edrophonium [Tensilon] to
confirm cholinergic crisis.
• B. Administer Atropine sulfate immediately to
reverse muscarinic toxicity.
• C. Increase the daily dose of neostigmine to
overcome neuromuscular blockade.
• D. Administer Epinephrine IV to stimulate
nicotinic-M receptors.
Correct Answer: B
Rationale: Extreme weakness accompanied by
"SLUDGEM" symptoms (Salivation, Lacrimation,
Urination, Diarrhea, GI distress, Emesis, Miosis)
indicates a cholinergic crisis caused by excessive
acetylcholinesterase inhibition. Administration of
Atropine sulfate (a muscarinic antagonist) is
,required to block excessive parasympathetic
stimulation. Administering edrophonium or
increasing neostigmine would dangerously worsen a
cholinergic crisis.
Question 2 (Autonomic Pharmacology: Beta-
Blockers & Comorbidities)
A patient with hypertension, prior myocardial
infarction, and type 1 diabetes mellitus is
prescribed a beta-adrenergic blocker. Which
safety principle must the nurse emphasize during
patient education?
• A. Beta-blockers stimulate glycogenolysis,
increasing the risk of hyperosmolar non-ketotic
coma.
• B. Non-selective beta-blockers can mask
symptoms of hypoglycemia (tachycardia,
tremors), leaving diaphoresis as the primary
remaining indicator.
• C. Cardioselective 𝛽1 -blockers cause severe
renal artery constriction in diabetic patients.
• D. Beta-blockers accelerate insulin clearance,
requiring a 50%reduction in daily insulin
dosage.
Correct Answer: B
, Rationale: Sympathetic activation during
hypoglycemia normally triggers tachycardia,
palpitations, and tremors. Beta-blockers inhibit these
sympathetic responses, masking classic warning
signs of low blood glucose. Diaphoresis (sweating)
is mediated by cholinergic sympathetic
postganglionic fibers and is typically not blocked by
beta-blockers, making it the primary signal for
hypoglycemia in these patients.
Question 3 (Analgesics: Opioid Adverse Effects &
Tolerance)
A patient receiving chronic IV hydromorphone
[Dilaudid] for severe cancer pain has developed
tolerance to the analgesic effects of the drug. To
which adverse effect of opioids does tolerance
NOT develop?
• A. Sedation
• B. Nausea and vomiting
• C. Respiratory depression
• D. Constipation
Correct Answer: D
Rationale: With chronic opioid administration,
patients develop tolerance to analgesia, sedation,
respiratory depression, and euphoria. However,
tolerance does NOT develop to constipation or